Making Healthy Habits Stick
Launched by UNIVERSITY OF TENNESSEE · Dec 17, 2024
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Making Healthy Habits Stick" is focused on helping women who are cancer survivors maintain a routine of physical activity. The goal is to support those who may face challenges due to health disparities and social disadvantages in staying active after their cancer treatment. This study is currently recruiting participants who are African American or Black women aged 19 and older, have a history of cancer, and have completed their primary cancer treatments like chemotherapy or radiation.
If you qualify, you can expect to participate in regular exercise sessions and attend both individual and group meetings through video calls. Participants will also complete surveys and assessments during the study. To be eligible, you’ll need to be able to move around without assistance and have access to a phone and email. It’s important to note that certain health conditions may exclude you from participating, so be sure to discuss your medical history with your doctor. This trial offers a chance to build lasting healthy habits in a supportive environment tailored for cancer survivors.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • woman age of 19 or older
- • identifies as African American or Black
- • have a history of cancer
- • have completed post-primary treatment for cancer (i.e., chemotherapy, radiation)
- • agree to allow research team to confirm cancer diagnosis with your physician
- • If received surgery, must be at least 8 weeks post-surgery
- • willing to have regular physician provide medical clearance for study participation
- • willing to provide home address if qualified for the study
- • willing and able to use videoconference platform such as Zoom for study activities (must be both willing and able)
- • willing and able to send and/or receive text messages (must be both willing and able)
- • has US phone number
- • has an email address
- • if has no email address, must be willing to create one
- • English speaking
- • Able to ambulate without assistance (does not need to use a cane, a walker, or a wheelchair)
- • willing and able to complete 3-5 exercise session per week on their own for the duration of the study; if answered no, please explain
- • willing to attend individual and group sessions via videoconferences during study participation; if answered no, please explain.
- • willing to attend assessments via videoconference during study participation; if answered no, please explain.
- • willing to complete surveys during study participation; if answered no, please explain.
- Exclusion Criteria:
- • Metastatic or recurrent cancer
- • another cancer diagnosis in the past 5 years (not including skin or cervical cancer in situ)
- • have severe orthopedic, joints or any other condition that stops individual from being active
- • unstable angina
- • have paint, tightness, or heaviness in chest EITHER when resting OR then physically active
- • have New York Heart Association class II, III, OR IV congestive heart failure
- • blood pressure has been over 160/100 at least twice in the past 6 months (either number; 160 or 100)
- • have uncontrolled asthma
- • have interstitial lung disease that requires extra oxygen
- • have dementia or organize brain syndrome
- • have schizophrenia or active psychosis
- • have had a stroke or other problem that left individual disables or with paralysis (unable to move or feel any part of body)
- • have hearing problems that make it hard to carry on a phone conversation
- • blind or partially blind
- • planned surgery during the first 6 month of study participation (if unapproved by PI)
- • planned knee or hip surgery during the first 6 month of study participation
- • anticipate changes in usual medications during the first 6 months of study participation (if unapproved by PI)
- • have been told by a physician to only do exercise prescribed by a physician
- • have been told by a physician to limit physical activity
- • have a contraindication to engaging in moderate intensity aerobic exercise
- • have completed on average, more than 90 min/week of moderate-intensity or more that 30 min/week of vigorous exercise in the past 6 months
- • trouble with balance or moving around safely
- • are currently pregnant or anticipate pregnant during study participation
- • currently participating in another exercise study
- • have BMI ≥ 50
About University Of Tennessee
The University of Tennessee is a leading research institution dedicated to advancing healthcare through innovative clinical trials. With a commitment to improving patient outcomes and fostering scientific discovery, the university engages in a diverse range of studies that encompass various medical disciplines. Leveraging its extensive resources, expert faculty, and state-of-the-art facilities, the University of Tennessee collaborates with healthcare professionals and industry partners to translate research findings into practical applications. Through rigorous ethical standards and a patient-centered approach, the university aims to contribute significantly to the field of medicine and enhance the well-being of communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Memphis, Tennessee, United States
Patients applied
Trial Officials
Michelle Martin, PhD
Principal Investigator
University of Tennessee
Laura Rogers, MD, MPH
Principal Investigator
University of Alabama at Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported